Johnson & Johnson vs. Maravai LifeSciences Holdings, Inc. Class A Common Stock
JNJ
Johnson & Johnson
$259.24 +0.88%
VS MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock
$6.23 -0.32%
Johnson & Johnson and Maravai LifeSciences Holdings, Inc. Class A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | MRVI | |
|---|---|---|
| Market Cap | $624.74 billion | $918.96 million |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | MRVI | |
|---|---|---|
| P/E Ratio | 30.07 | — |
| Price / Book | 7.35 | — |
| Price / Sales | 6.38 | — |
JNJ and MRVI split the valuation factors evenly.
Profitability
| JNJ | MRVI | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | — |
JNJ and MRVI split the profitability factors evenly.
Dividend
| JNJ | MRVI | |
|---|---|---|
| Dividend Yield | 2.07% | — |
| Payout Ratio | 62.18 | — |
JNJ and MRVI split the dividend factors evenly.
Risk & Sentiment
| JNJ | MRVI | |
|---|---|---|
| Short Interest | 0.67% | 0.43% |
MRVI leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, MRVI overview, MRVI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.